Angiographic response of locally advanced soft-tissue sarcoma following hyperthermic isolated limb perfusion with tumor necrosis factor

被引:55
|
作者
Olieman, AFT
vanGinkel, RJ
Hoekstra, HJ
Mooyaart, EL
Molenaar, WM
Koops, HS
机构
[1] UNIV GRONINGEN HOSP,DEPT SURG ONCOL,NL-9700 RB GRONINGEN,NETHERLANDS
[2] UNIV GRONINGEN HOSP,DEPT RADIOL,NL-9700 RB GRONINGEN,NETHERLANDS
[3] UNIV GRONINGEN HOSP,DEPT PATHOL,NL-9700 RB GRONINGEN,NETHERLANDS
关键词
hyperthermic isolated limb perfusion; angiography; sarcoma; tumor necrosis factor;
D O I
10.1007/BF02316812
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Hyperthermic isolated limb perfusion (HILP) with tumor necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma), and melphalan is associated with a dramatic anti-tumor effect in which the neo-vascularization of the tumor is supposed to be the major target, The aim of the present study was to correlate the angiographic findings with the pathological response in patients undergoing HILP for locally advanced soft-tissue sarcoma, Patients and Methods: Twenty-five patients, 14 male and 11 female, mean age 47 years (range 18-80) were studied. Angiographies were performed before and a median period of 7 weeks (range 4-14 weeks) after HILP. Eight weeks after perfusion, the residual tumor mass was resected and pathologically examined, The changes in tumor vascularization after treatment were scored and compared with the pathological response, Results: All baseline angiograms showed a hypervascular tumor. After HILP, a normal angiography result (NA) was observed in 18 patients (72%) and an abnormal angiography result (AA) was observed in seven patients (28%). All patients with an NA showed a pathologically complete response (pCR) or a pathological partial response with >90% necrosis of the tumor, Of seven patients with an AA, pathological examination showed a PCR in one patient, 10-50% viable tumor volume in four patients, and no pathological response after perfusion in two patients. A good correlation was seen between angiographic and pathological classification (p < 0.001), Conclusion: An angiography performed after hyperthermic isolated limb perfusion with TNF-alpha and melphalan provides a good indication, regardless of whether a good pathological response is expected.
引用
收藏
页码:64 / 69
页数:6
相关论文
共 50 条
  • [1] Angiographic response of locally advanced soft-tissue sarcoma following hyperthermic isolated limb perfusion with tumor necrosis factor
    Annette F. T. Olieman
    Robert J. van Ginkel
    Harald J. Hoekstra
    Eduard L. Mooyaart
    Willemina M. Molenaar
    Heimen Schraffordt Koops
    Annals of Surgical Oncology, 1997, 4 : 64 - 69
  • [2] Isolated limb perfusion with melphalan and tumor necrosis factor α for advanced melanoma and soft-tissue sarcoma
    Hayes, Andrew J.
    Neuhaus, Susan J.
    Clark, Matthew A.
    Thomas, J. Meirion
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (01) : 230 - 238
  • [3] Isolated Limb Perfusion With Melphalan and Tumor Necrosis Factor α for Advanced Melanoma and Soft-Tissue Sarcoma
    Andrew J. Hayes
    Susan J. Neuhaus
    Matthew A. Clark
    J. Meirion Thomas
    Annals of Surgical Oncology, 2007, 14 : 230 - 238
  • [4] FDG-PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma
    vanGinkel, RJ
    Hoekstra, HJ
    Pruim, J
    Nieweg, OE
    Molenaar, WM
    Paans, AMJ
    Willemsen, ATM
    Vaalburg, W
    Koops, HS
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (06) : 984 - 990
  • [5] Hyperthermic Isolated Limb Perfusion With Tumor Necrosis Factor-α and Melphalan in Advanced Soft-Tissue Sarcomas: Histopathological Considerations
    Josephine Issakov
    Ofer Merimsky
    Mordechai Gutman
    Yehuda Kollender
    Dina Lev-Chelouche
    Soubhi Abu-Abid
    Beatriz Lifschitz-Mercer
    Moshe Inbar
    Joseph M. Klausner
    Isaac Meller
    Annals of Surgical Oncology, 2000, 7 : 155 - 159
  • [6] Hyperthermic isolated limb perfusion with tumor necrosis factor-α and melphalan in advanced soft-tissue sarcomas:: Histopathological considerations
    Issakov, J
    Merimsky, O
    Gutman, M
    Kollender, Y
    Lev-Chelouche, D
    Abu-Abid, S
    Lifschitz-Mercer, B
    Inbar, M
    Klausner, JM
    Meller, I
    ANNALS OF SURGICAL ONCOLOGY, 2000, 7 (02) : 155 - 159
  • [7] Isolated limb perfusion with tumor necrosis factor α and melphalan for locally advanced soft tissue sarcoma:: The value of adjuvant radiotherapy
    Thijssens, KMJ
    van Ginkel, RJ
    Pras, E
    Suurmeijer, AJH
    Hoekstra, HJ
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (04) : 518 - 524
  • [8] Isolated Limb Perfusion With Tumor Necrosis Factor α and Melphalan for Locally Advanced Soft Tissue Sarcoma: The Value of Adjuvant Radiotherapy
    Katja M. J. Thijssens
    Robert J. van Ginkel
    Elisabeth Pras
    Albert J. H. Suurmeijer
    Harald J. Hoekstra
    Annals of Surgical Oncology, 2006, 13 : 518 - 524
  • [9] Multifocal soft tissue sarcoma: Limb salvage following hyperthermic isolated limb perfusion with high-dose tumor necrosis factor and melphalan
    Lev-Chelouche, D
    Abu-Abeid, S
    Kollander, Y
    Meller, I
    Isakov, J
    Merimsky, I
    Klausner, JM
    Gutman, M
    JOURNAL OF SURGICAL ONCOLOGY, 1999, 70 (03) : 185 - 189
  • [10] ISOLATED LIMB PERFUSION WITH TUMOR-NECROSIS-FACTOR AND MELPHALAN - A NEW METHOD IN THE TREATMENT OF REGIONAL MELANOMA METASTASES AND LOCALLY ADVANCED SOFT-TISSUE SARCOMA
    SCHLAG, PM
    KETTELHACK, C
    ONKOLOGIE, 1995, 18 (02): : 123 - 125